These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21380637)

  • 1. Diagnosis and treatment of osteoporosis before and after admission to long-term care institutions.
    Beaupre LA; Majumdar SR; Dieleman S; Au A; Morrish DW
    Osteoporos Int; 2012 Feb; 23(2):573-80. PubMed ID: 21380637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment for older men with fractures.
    Shepherd AJ; Cass AR; Ray LA; Tan A; Wilkinson GS
    Osteoporos Int; 2012 Mar; 23(3):1041-51. PubMed ID: 21811867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.
    Kennedy CC; Ioannidis G; Thabane L; Adachi JD; Marr S; Giangregorio LM; Morin SN; Crilly RG; Josse RG; Lohfeld L; Pickard LE; van der Horst ML; Campbell G; Stroud J; Dolovich L; Sawka AM; Jain R; Nash L; Papaioannou A
    Trials; 2015 May; 16():214. PubMed ID: 25962885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association Between Long-Term Bisphosphonate Use and the Risk of Fracture Among Women Aged 50 or Older with Osteoporosis.
    Wang CC; Lu HT; Dusetzina SB; Wu CH
    J Womens Health (Larchmt); 2016 Jul; 25(7):738-46. PubMed ID: 27096405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis prevalence and characteristics of treated and untreated nursing home residents with osteoporosis.
    Zarowitz BJ; Cheng LI; Allen C; O'Shea T; Stolshek B
    J Am Med Dir Assoc; 2015 Apr; 16(4):341-8. PubMed ID: 25726417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials.
    Majumdar SR; McAlister FA; Johnson JA; Weir DL; Bellerose D; Hanley DA; Russell AS; Rowe BH
    Osteoporos Int; 2014 Sep; 25(9):2173-9. PubMed ID: 24803330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of combined oral bisphosphonate therapy and falls prevention exercise for fracture prevention in the USA.
    Mori T; Crandall CJ; Ganz DA
    Osteoporos Int; 2017 Feb; 28(2):585-595. PubMed ID: 27726000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of change in bone mineral density and fracture risk during bisphosphonate holiday.
    Xu LH; Adams-Huet B; Poindexter JR; Maalouf NM
    Osteoporos Int; 2016 May; 27(5):1701-8. PubMed ID: 26642963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of osteoporotic fracture risk factors and antiosteoporotic treatments in the Valencia region, Spain. The baseline characteristics of the ESOSVAL cohort.
    Sanfélix-Genovés J; Sanfélix-Gimeno G; Peiró S; Hurtado I; Fluixà C; Fuertes A; Campos JC; Giner V; Baixauli C
    Osteoporos Int; 2013 Mar; 24(3):1045-55. PubMed ID: 22618269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate use after clinical fracture and risk of new fracture.
    Bergman J; Nordström A; Nordström P
    Osteoporos Int; 2018 Apr; 29(4):937-945. PubMed ID: 29397408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisphosphonate and denosumab initiation in older adults in Ontario, Canada: a population-based cohort study.
    Clemens KK; Jeyakumar N; Ouédraogo AM; Thain J; Khan T
    Arch Osteoporos; 2020 Aug; 15(1):133. PubMed ID: 32816151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates.
    Hadji P; Claus V; Ziller V; Intorcia M; Kostev K; Steinle T
    Osteoporos Int; 2012 Jan; 23(1):223-31. PubMed ID: 21308365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Drug Therapy and Drug Discontinuations and Holidays for Osteoporosis Fracture Prevention: A Systematic Review.
    Fink HA; MacDonald R; Forte ML; Rosebush CE; Ensrud KE; Schousboe JT; Nelson VA; Ullman K; Butler M; Olson CM; Taylor BC; Brasure M; Wilt TJ
    Ann Intern Med; 2019 Jul; 171(1):37-50. PubMed ID: 31009947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Hip Fracture Despite Treatment with Bisphosphonates among Frail Older Adults.
    Zullo AR; Sorial MN; Lee Y; Lary CW; Kiel DP; Berry SD
    J Am Geriatr Soc; 2020 Feb; 68(2):256-260. PubMed ID: 31580488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Denosumab utilization among older adults in Ontario: patient characteristics, persistence with therapy, and return to therapy after an extended gap.
    Ban JK; Hao BB; McCarthy L; Guilcher SJT; Cadarette SM
    Osteoporos Int; 2019 Sep; 30(9):1865-1872. PubMed ID: 31317248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonate effectiveness in patients with cirrhosis: An emulated clinical trial.
    Tapper EB; Martinez B; Jepsen P; Chen X; Parikh ND
    Aliment Pharmacol Ther; 2024 Sep; 60(5):585-592. PubMed ID: 38922994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.
    Fleurence RL; Iglesias CP; Johnson JM
    Pharmacoeconomics; 2007; 25(11):913-33. PubMed ID: 17960951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk.
    Mignot MA; Taisne N; Legroux I; Cortet B; Paccou J
    Osteoporos Int; 2017 Dec; 28(12):3431-3438. PubMed ID: 28875236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Wildpaner D; Pavese C; Weber M
    Praxis (Bern 1994); 2017 Apr; 106(8):421-427. PubMed ID: 28401777
    [No Abstract]   [Full Text] [Related]  

  • 20. Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial.
    McAlister FA; Ye C; Beaupre LA; Rowe BH; Johnson JA; Bellerose D; Hassan I; Majumdar SR
    Osteoporos Int; 2019 Jan; 30(1):127-134. PubMed ID: 30232538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.